| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.2M | — | -50.6% |
| R&D Expense | $10.6M | — | +33.0% |
| SG&A Expense | $5.9M | — | -6.3% |
| Operating Income | -$14.4M | — | -44.7% |
| Pre-tax Income | -$65.5M | — | -699.8% |
| Income Tax | $0 | — | — |
| Net Income | -$65.5M | — | -699.8% |
| EPS (Basic) | -$0.75 | — | -212.5% |
| EPS (Diluted) | -$0.75 | — | -212.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $60.0M | +33.0% | +43.5% |
| Accounts Receivable | $1.7M | -13.2% | -43.8% |
| Current Assets | $66.6M | +33.1% | +39.0% |
| Total Assets | $66.8M | +32.9% | +38.7% |
| Current Liabilities | $9.3M | +20.0% | -61.5% |
| Long-term Debt | $1.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$12.7M | — | -41.5% |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $27.6M | — | +34.8% |
| — |
| Total Liabilities | $87.9M | +151.9% | +262.4% |
| Stockholders' Equity | -$45.8M | -398.6% | -1003.5% |